Sava Infond’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.29M Sell
16,905
-1,640
-9% -$382K 0.3% 61
2026
Q1
$4.53M Buy
18,545
+525
+3% +$122K 0.64% 36
2025
Q4
$3.73M Buy
18,020
+1,200
+7% +$237K 0.5% 41
2025
Q3
$3.12M Buy
16,820
+2,500
+17% +$428K 0.44% 43
2025
Q2
$2.19M Buy
14,320
+830
+6% +$128K 0.34% 56
2025
Q1
$2.24M Sell
13,490
-1,140
-8% -$178K 0.43% 49
2024
Q4
$2.12M Buy
+14,630
New +$2.27M 0.37% 52

Other funds holding JNJ

Sava Infond's JNJ Position: Q2 2026 in Review

Sava Infond reduced its Johnson & Johnson (JNJ) stake by 8.8% in Q2 2026, selling an estimated $382K and leaving 16,905 shares worth $4.29M. The position accounts for 0.3% of the portfolio, ranked #61.

Sava Infond first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.53M in Q1 2026. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Sava Infond held 16,905 shares of Johnson & Johnson worth $4.29M as of Q2 2026.
  • Sava Infond sold 1,640 Johnson & Johnson shares in Q2 2026, an estimated $382K.
  • Johnson & Johnson made up 0.3% of Sava Infond's portfolio in Q2 2026, its #61 holding.
  • Sava Infond first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • Sava Infond's Johnson & Johnson position peaked at $4.53M in Q1 2026.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.